Cerebrolysin — dosage, half-life & reference guide

Cognitive peptide · also known as FPE 1070, Cerebrolysin injection

A complex mixture of neurotrophic peptides derived from porcine brain tissue, containing BDNF, NGF, and other growth factors. Cerebrolysin is used clinically in many countries for stroke recovery, traumatic brain injury, and dementia. Administered in intensive 10-20 day courses a few times per year — one of the few cognitive peptides with established clinical use.

Commonly-researched dose ranges

Cerebrolysin is commonly researched at 5–10 ml, daily for 10–20 day cycles, by IM injection, IV infusion (clinical setting). These are reference ranges from the literature and community use, not a prescription.

Half-life

Estimated half-life: Short (component peptides). See how it accumulates in the half-life calculator.

Safety & interactions

Commonly reported effects: injection site reactions, dizziness, warm sensation during iv infusion, headache. Discuss with your clinician.

Open the full Cerebrolysin guide (needs JavaScript). PepVault is a private research and tracking tool, not medical advice.